Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malini Viswanathan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Immunological Methods|December 4, 2001
Selection of high affinity p-azophenyarsonate Fabs from heavy-chain CDR2 insertion librariesBehnaz Parhami-Seren, Malini Viswanathan, Michael N Margolies
Current Opinion in Biotechnology|October 20, 2006
Therapeutic peptides: technological advances driving peptides into developmentAaron K Sato, Malini Viswanathan, Rachel B Kent, et al.
Drug Discovery Today|April 15, 2008
Screening isolates from antibody phage-display librariesDavid R Buckler, Albert Park, Malini Viswanathan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Engineering antibody heavy chain CDR3 to create a phage display Fab library rich in antibodies that bind charged carbohydratesSonia Schoonbroodt, Mieke Steukers, Malini Viswanathan, et al.
Biotechnology and Bioengineering|May 28, 2011
Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturabilityGreg P Conley, Malini Viswanathan, Ying Hou, et al.
Frontiers in Immunology|May 9, 2015
Fully human monoclonal antibody inhibitors of the neonatal fc receptor reduce circulating IgG in non-human primatesAndrew E Nixon, Jie Chen, Daniel J Sexton, et al.
The Journal of Biological Chemistry|February 22, 2007
Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrateRobert Hills, Richard Mazzarella, Kam Fok, et al.
The Journal of Biological Chemistry|June 28, 2014
Inhibition of plasma kallikrein by a highly specific active site blocking antibodyJon A Kenniston, Ryan R Faucette, Diana Martik, et al.
Nature Biotechnology|February 22, 2005
Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversityRené Michael Hoet, Edward H Cohen, Rachel Baribault Kent, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Immunological Methods|December 4, 2001
Selection of high affinity p-azophenyarsonate Fabs from heavy-chain CDR2 insertion librariesBehnaz Parhami-Seren, Malini Viswanathan, Michael N Margolies
Current Opinion in Biotechnology|October 20, 2006
Therapeutic peptides: technological advances driving peptides into developmentAaron K Sato, Malini Viswanathan, Rachel B Kent, et al.
Drug Discovery Today|April 15, 2008
Screening isolates from antibody phage-display librariesDavid R Buckler, Albert Park, Malini Viswanathan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Engineering antibody heavy chain CDR3 to create a phage display Fab library rich in antibodies that bind charged carbohydratesSonia Schoonbroodt, Mieke Steukers, Malini Viswanathan, et al.
Biotechnology and Bioengineering|May 28, 2011
Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturabilityGreg P Conley, Malini Viswanathan, Ying Hou, et al.
Frontiers in Immunology|May 9, 2015
Fully human monoclonal antibody inhibitors of the neonatal fc receptor reduce circulating IgG in non-human primatesAndrew E Nixon, Jie Chen, Daniel J Sexton, et al.
The Journal of Biological Chemistry|February 22, 2007
Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrateRobert Hills, Richard Mazzarella, Kam Fok, et al.
The Journal of Biological Chemistry|June 28, 2014
Inhibition of plasma kallikrein by a highly specific active site blocking antibodyJon A Kenniston, Ryan R Faucette, Diana Martik, et al.
Nature Biotechnology|February 22, 2005
Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversityRené Michael Hoet, Edward H Cohen, Rachel Baribault Kent, et al.
Pageof 1